Bronchodilators - What Are Bronchodilators Video - About.com
Links shared publicly online about this topic.
- 1,170total visits
Bronchodilators - What Are Bronchodilators Video - About.com
View full resource at video.about.com
Most Recently Shared on June 6, 2010 at 1:13 am By:
What Are Bronchodilators? Check Out This Video That Shows How Your Rescue Inhaler Works http://cli.gs/MgMXXV
Changes in Inhaler Devices for Asthma And COPD - Health News - redOrbit
redorbit.com — “Asthma and chronic obstructive pulmonary disease (COPD) involve chronic inflammation and constriction of the bronchioles. Optimal therapy for many patients requires control of both pathologic mechanisms through the use of inhaled bronchodilators and corticosteroids.” View full resource at redorbit.com
Most Recently Shared on March 27, 2012 at 12:40 pm By:
Commented on: Changes in Inhaler Devices for Asthma And COPD: http://t.co/uh0MmiEz
Quercetin for Allergic Asthma | Health and Wellness News
wellnessresources.com — “For two decades, quercetin has claimed nutritional fame as the most potent natural anti-histamine available. Numerous studies have demonstrated that quercetin reduces allergic immune response by modulating inflammatory signals at the gene level. A new animal study demonstrates that a single dose of quercetin can have a potent bronchodilator effect, offering a potential strategy for people with asthma looking for natural ways to help assist them.” View full resource at wellnessresources.com
Most Recently Shared on March 26, 2012 at 6:24 pm By:
Wellness Resources Health Business
Asthma? Allergies? Here’s a natural way to help calm down allergy-related breathing problems. http://t.co/00HTMiXp
Novartis launches Arcapta Neohaler, a novel once-daily bronchodilator for chronic obstructive pulmonary disease - Drugs.com MedNews
drugs.com — “- Arcapta Neohaler is the only once-daily, 24-hour long-acting beta2-agonist approved for maintenance treatment of airflow obstruction in COPD patients Novartis” View full resource at drugs.com
Most Recently Shared on March 20, 2012 at 12:07 pm By:
Drugs and Devices OW OW Health
Novartis launches Arcapta Neohaler, a novel once-daily bronchodilator for chronic obstructive pulmonary di... http://t.co/fZkiPS6X #drug
Although the past... | Facebook
facebook.com — “Journal of Allergy and Clinical Immunology wrote: Although the past few years have... Join Facebook to connect with Journal of Allergy and Clinical Immunology and others you may know.” View full resource at facebook.com
Most Recently Shared on March 20, 2012 at 4:13 am By:
Juan C. Ivancevich, MD Physician, Doctor, Internist, and Allergist
Prevalence of asthma and bronchodilator reversibility in adults with HIV. http://t.co/Vjtz1vFi
Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: EAST HANOVER, N.J., March 19, 2012 /PRNewswire/ -- Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta™ Neohaler™ (indacaterol inhalation powder) 75 mcg is now available in the ...” View full resource at finance.yahoo.com
Most Recently Shared on March 19, 2012 at 9:41 pm By:
Novartis launches Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary diseas... http://t.co/8ejHWYvT
Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease - MarketWatch
marketwatch.com — “Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary disease - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on March 19, 2012 at 9:20 pm By:
Michael Blaiss, MD Physician, Doctor, and Allergist
Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator for chronic obstructive pulmonary dis... http://t.co/TDxSDBVI
Pearl Therapeutics completes two PT003 Phase 2b clinical studies on COPD
news-medical.net — “Pearl Therapeutics Inc. today announced the completion of two Phase 2b clinical studies of PT003, the Company's investigational inhaled combination bronchodilator product for the treatment of patients with moderate-to-severe COPD.” View full resource at news-medical.net
Most Recently Shared on January 7, 2012 at 12:06 pm By:
Asthma News: Pearl Therapeutics completes two PT003 Phase 2b clinical studies on COPD: Pearl Therapeutics Inc. t... http://t.co/TmsD9E88
Lower Urinary Tract Symptoms In Men Associated With Common Medications
medicalnewstoday.com — “Use of selected prescription medications, including antidepressants, antihistamines, bronchodilators, anticholinergics, sympathomimetics, and diuretics contribute to 10 percent of lower urinary tr” View full resource at medicalnewstoday.com
Most Recently Shared on October 12, 2011 at 10:05 am By:
Lower Urinary Tract Symptoms In Men Associated With Common Medications http://t.co/bwWFKyIQ #menshealth
Common medications can contribute to lower urinary tract symptoms in men
medicalxpress.com — “Use of selected prescription medications, including antidepressants, antihistamines, bronchodilators, anticholinergics, sympathomimetics, and diuretics contribute to 10 percent of lower urinary tract symptoms among men according to a Kaiser Permanente study published in the Archives of Internal Medicine.” View full resource at medicalxpress.com
Most Recently Shared on October 11, 2011 at 2:33 pm By:
PhysOrg Health News Health News
Common medications can contribute to lower urinary tract symptoms in men http://t.co/rGLpnum0
Selected prescription drugs contribute to 10% of lower urinary tract symptoms among men
news-medical.net — “Use of selected prescription medications, including antidepressants, antihistamines, bronchodilators, anticholinergics, sympathomimetics, and diuretics contribute to 10 percent of lower urinary tract symptoms among men according to a Kaiser Permanente study published in the Archives of Internal Medicine.” View full resource at news-medical.net
Most Recently Shared on October 11, 2011 at 9:40 am By:
Urology & Nephrology OW Health
Selected prescription drugs contribute to 10% of lower urinary tract symptoms among men: Use of selected prescri... http://t.co/mgTfnheW
Selected prescription drugs contribute to 10% of lower urinary tract symptoms among men
news-medical.net — “Use of selected prescription medications, including antidepressants, antihistamines, bronchodilators, anticholinergics, sympathomimetics, and diuretics contribute to 10 percent of lower urinary tract symptoms among men according to a Kaiser Permanente study published in the Archives of Internal Medicine.” View full resource at news-medical.net
Most Recently Shared on October 11, 2011 at 6:34 am By:
Cancer News Selected prescription drugs contribute to 10% of lower urinary tract symptoms among men: Use of sele... http://t.co/6HMCHj3R
Emergency Medicine Article | Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult Patients
mdlinx.com — “Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult Patients” View full resource at mdlinx.com
Most Recently Shared on October 6, 2011 at 10:22 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult Patients: Chest http://t.co/HPRywJQf #ER
Maternal bronchodilator use and the risk of orofacial clefts
humrep.oxfordjournals.org — “Maternal bronchodilator use and the risk of orofacial clefts” View full resource at humrep.oxfordjournals.org
Most Recently Shared on September 22, 2011 at 12:05 pm By:
Juan C. Ivancevich, MD Physician, Doctor, Internist, and Allergist
Association between maternal bronchodilator use during the periconceptional period and the risk of cleft lip http://t.co/dW2gYpHp
Respiratory Research | Abstract | Treatment of allergic asthma: Modulation of Th2 cells and their responses
respiratory-research.com — “Atopic asthma is a chronic inflammatory pulmonary disease characterised by recurrent episodes of wheezy, laboured breathing with an underlying Th2 cell-mediated inflammatory response in the airways. It is currently treated and, more or less, controlled depending on severity, with bronchodilators e.g. long-acting beta agonists and long-acting muscarinic antagonists or anti-inflammatory drugs such as corticosteroids (inhaled or oral), leukotriene modifiers, theophyline and anti-IgE therapy. Unfort” View full resource at respiratory-research.com
Most Recently Shared on August 29, 2011 at 6:42 pm By:
active medicine team Health Business
#respiratoryresearch Treatment of allergic asthma: Modulation of Th2 cells and their responses http://t.co/W3aZMSf
Bronchodilation in asthmatics maintained with daily dosing of RPL554 - Drugs.com MedNews
drugs.com — “Highlights Identical bronchodilator responses seen after 1, 3 and 6 days of treatment No evidence of RPL554 accumulation in plasma over 6 days There were no saf” View full resource at drugs.com
Most Recently Shared on August 23, 2011 at 7:14 pm By:
Drugs and Devices OW OW Health
Bronchodilation in asthmatics maintained with daily dosing of RPL554: Highlights • Identical bronchodilato... http://t.co/9zbiDF1 #drug
Advertisement
